← Eichor
Study identifier: NCT07250750 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

Condition: Myasthenia Gravis  ·  Sponsor: ImmunAbs Inc.

PhasePhase 1/Phase 2
Planned participants96
Who can joinAll sexes, 18 Years to 74 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of IM-101 in adult participants with AChR antibody-positive gMG. Subsequently, the safety and efficacy of the selected IM-101 dose-regimen will be tested in participants with AChR antibody-negative gMG and participants with AChR antibody-positive or AChR antibody-negative oMG.

This description comes directly from the study's public registry record.

Talk to the study team

ImmunAbs Clinical Team  ·  82-2-6951-0584  ·  info@immunabs.com

Always discuss trial participation with your own doctor first.

Locations (25)

Neurology of Central Florida Research Center, LLCAltamonte Springs, Florida, United StatesRecruiting
SFM Clinical Research, LLCBoca Raton, Florida, United StatesRecruiting
Aqualane Clinical ResearchNaples, Florida, United StatesRecruiting
Medsol Clinical Research CenterPort Charlotte, Florida, United StatesNot Yet Recruiting
University of South FloridaTampa, Florida, United StatesNot Yet Recruiting
University of Kansas Medical Center Research Institute, Inc.Kansas City, Missouri, United StatesNot Yet Recruiting
Nerve & Muscle Center of TexasHouston, Texas, United StatesRecruiting
Houston Methodist Neurological InstituteHouston, Texas, United StatesNot Yet Recruiting
Medical Center Hera - branch MontanaMontana, BulgariaNot Yet Recruiting
"MHAT Avis - Medica" OODPleven, BulgariaNot Yet Recruiting
UMHAT 'Dr. Georgi Stranski', EADPleven, BulgariaNot Yet Recruiting
UMHAT 'Tsaritsa Yoanna - ISUL', EADSofia, BulgariaNot Yet Recruiting

+ 13 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07250750